Kimberly-Clark 4Q results miss earnings estimates

Health and hygiene company, Kimberly-Clark Corporation reported mixed 4Q18 results on Wednesday (23 January), with revenue at $4.57bn vs $4.60bn posted in 4Q17, while diluted EPS came in at $1.60 compared with $1.57 recorded in the same period of 2017. Revenue came in above the Refinitiv consensus analyst expectations of $4.45bn, as the firm raised its prices to offset higher raw material and transportation costs, but earnings disappointed coming in below the $1.68 Refinitiv consensus analysts’ estimate.

Fourth-quarter operating profit was $639mn, including charges related to its 2018 global restructuring programme. Results were impacted by $215mn more in raw material costs, including $115mn for pulp, the major ingredient in its tissues, diapers and sanitary pads. Net income was down 33% YoY to $411mn, or $1.18/share. 

Organic sales were even in developed markets (DMs) and rose 4% YoY in emerging markets (EMs). In terms of segments, Personal Care recorded 4Q18 sales of $2.2bn (-2% YoY), while Consumer Tissue revenue came in at $1.5bn (basically flat) and the K-C Professional (KCP) segment posted sales of $841mn (+2% YoY).

The firm’s gross margin was squeezed by 420 bpts to 30.7%.

During the quarter, the company repurchased 1.8mn shares for $199mn.

Looking ahead, for FY19, the company said it expects EPS to be between $6.50 and $6.70.



Submit your details and we’ll give you a call back to assist and advise you on your investment.


Subscribe to our newsletters to receive regular market commentary, research and updates from the Anchor team. Select between our Individual or Financial Advisor newsletters by selecting the relevant tab below.

Insights and commentary to help you navigate markets.

Subscribe to Anchor's daily Current Co-ordinates newsletter.

Newsletter popup